Sustained response to tumor necrosis factor α–blocking agents in two patients with SAPHO syndrome
- 11 July 2002
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (7) , 1965-1968
- https://doi.org/10.1002/art.10539
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pamidronate: a novel treatment for the SAPHO syndrome?Rheumatology, 2002
- Acne with chronic recurrent multifocal osteomyelitis involvingthe mandible as part of the SAPHO syndrome: case reportBritish Journal of Oral and Maxillofacial Surgery, 2001
- SAPHO: Rare or just not recognized?Seminars in Arthritis and Rheumatism, 2000
- Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximabArthritis & Rheumatism, 2000
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- SAPHO syndrome: A long-term follow-up study of 120 casesSeminars in Arthritis and Rheumatism, 1999
- The SAPHO syndromeBailliere's Clinical Rheumatology, 1994
- Propionibacterium acnes in a spondylitis with palmoplantar pustulosis.Annals of the Rheumatic Diseases, 1990
- Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis.Annals of the Rheumatic Diseases, 1988
- Osteomyelitis of cervical spine from propionibacterium acnesArthritis & Rheumatism, 1982